Patents Assigned to Aqtual, Inc.
  • Methods for sequencing samples
    Patent number: 11965211
    Abstract: Personalized medicine involves the use of a patient's molecular markers to guide treatment regimens for the patient. The scientific literature provides multiple examples of correlations between drug treatment efficacy and the presence or absence of molecular markers in a patient sample. Methods are provided herein that permit efficient dissemination of scientific findings regarding treatment efficacy and molecular markers found in patient tumors to health care providers.
    Type: Grant
    Filed: October 8, 2018
    Date of Patent: April 23, 2024
    Assignee: Aqtual, Inc.
    Inventors: Dietrich Stephan, Vern Norviel, Janet Warrington, Doug Dolginow